Journal of Clinical Medicine (Aug 2023)

Performance of Prognostic Scoring Systems in MINOCA: A Comparison among GRACE, TIMI, HEART, and ACEF Scores

  • Damiano Fedele,
  • Lisa Canton,
  • Francesca Bodega,
  • Nicole Suma,
  • Francesco Pio Tattilo,
  • Andrea Impellizzeri,
  • Sara Amicone,
  • Ornella Di Iuorio,
  • Khrystyna Ryabenko,
  • Matteo Armillotta,
  • Angelo Sansonetti,
  • Andrea Stefanizzi,
  • Daniele Cavallo,
  • Marcello Casuso,
  • Davide Bertolini,
  • Luigi Lovato,
  • Emanuele Gallinoro,
  • Marta Belmonte,
  • Andrea Rinaldi,
  • Francesco Angeli,
  • Gianni Casella,
  • Alberto Foà,
  • Luca Bergamaschi,
  • Pasquale Paolisso,
  • Carmine Pizzi

DOI
https://doi.org/10.3390/jcm12175687
Journal volume & issue
Vol. 12, no. 17
p. 5687

Abstract

Read online

Background: the prognosis of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) is not benign; thus, prompting the need to validate prognostic scoring systems for this population. Aim: to evaluate and compare the prognostic performance of GRACE, TIMI, HEART, and ACEF scores in MINOCA patients. Methods: A total of 250 MINOCA patients from January 2017 to September 2021 were included. For each patient, the four scores at admission were retrospectively calculated. The primary outcome was a composite of all-cause death and acute myocardial infarction (AMI) at 1-year follow-up. The ability to predict 1-year all-cause death was also tested. Results: Overall, the tested scores presented a sub-optimal performance in predicting the composite major adverse event in MINOCA patients, showing an AUC ranging between 0.7 and 0.8. Among them, the GRACE score appeared to be the best in predicting all-cause death, reaching high specificity with low sensitivity. The best cut-off identified for the GRACE score was 171, higher compared to the cut-off of 140 generally applied to identify high-risk patients with obstructive AMI. When the scores were tested for prediction of 1-year all-cause death, the GRACE and the ACEF score showed very good accuracy (AUC = 0.932 and 0.828, respectively). Conclusion: the prognostic scoring tools, validated in AMI cohorts, could be useful even in MINOCA patients, although their performance appeared sub-optimal, prompting the need for risk assessment tools specific to MINOCA patients.

Keywords